AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+1.26%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.39B
AUM Growth
+$4.39B
Cap. Flow
-$46.2M
Cap. Flow %
-1.05%
Top 10 Hldgs %
49.11%
Holding
164
New
19
Increased
18
Reduced
12
Closed
14

Top Buys

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38.8M
2
OTLY
Oatly Group
OTLY
$36.7M
3
TRML icon
Tourmaline Bio
TRML
$30.3M
4
VERV
Verve Therapeutics
VERV
$30.1M
5
LENZ
LENZ Therapeutics
LENZ
$21.5M

Top Sells

1
BNTX icon
BioNTech
BNTX
$98.3M
2
INTC icon
Intel
INTC
$51.2M
3
CCXI
ChemoCentryx, Inc.
CCXI
$38.4M
4
AVGO icon
Broadcom
AVGO
$34.8M
5
BEKE icon
KE Holdings
BEKE
$34.2M

Sector Composition

1 Healthcare 83.34%
2 Consumer Discretionary 12.19%
3 Consumer Staples 0.83%
4 Industrials 0.53%
5 Materials 0.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
WW
1
DELISTED
WW International
WW
$536M 10.87% 14,818,300 – –
LXRX icon
2
Lexicon Pharmaceuticals
LXRX
$400M
$327M 6.63% 71,178,364 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$292M 5.92% 850,000 – –
SEER icon
4
Seer Inc
SEER
$115M
$183M 3.72% 5,588,366 – –
XLRN
5
DELISTED
Acceleron Pharma Inc.
XLRN
$176M 3.57% 1,400,000 – –
ARGX icon
6
argenx
ARGX
$43.6B
$151M 3.06% 500,000 +50,000 +11% +$15.1M
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$137M 2.79% 850,000 +125,000 +17% +$20.2M
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$58.5B
$127M 2.58% 750,000 – –
FATE icon
9
Fate Therapeutics
FATE
$120M
$117M 2.38% 1,350,000 +50,000 +4% +$4.34M
RUBY
10
DELISTED
Rubius Therapeutics, Inc
RUBY
$113M 2.3% 4,633,791 -250,000 -5% -$6.1M
MORF
11
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$104M 2.12% 1,819,186 – –
IGMS
12
DELISTED
IGM Biosciences
IGMS
$91.5M 1.86% 1,100,000 -25,000 -2% -$2.08M
GBIO icon
13
Generation Bio
GBIO
$40.4M
$75.7M 1.54% 2,814,191 – –
IMAB
14
I-MAB
IMAB
$340M
$63M 1.28% 750,000 – –
SDGR icon
15
Schrodinger
SDGR
$1.44B
$60.3M 1.22% 797,445 – –
SRRK icon
16
Scholar Rock
SRRK
$3.14B
$57.8M 1.17% 2,000,000 – –
SAGE
17
DELISTED
Sage Therapeutics
SAGE
$56.8M 1.15% 1,000,000 +350,000 +54% +$19.9M
CERE
18
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$51.2M 1.04% 2,000,000 -500,000 -20% -$12.8M
KLRS
19
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$45.9M 0.93% 2,323,371 – –
SWTX
20
DELISTED
SpringWorks Therapeutics
SWTX
$41.2M 0.84% 500,000 +100,000 +25% +$8.24M
NTLA icon
21
Intellia Therapeutics
NTLA
$1.22B
$40.5M 0.82% 250,000 – –
DNLI icon
22
Denali Therapeutics
DNLI
$2.23B
$39.2M 0.8% 500,000 – –
BHVN
23
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38.8M 0.79% +400,000 New +$38.8M
OTLY
24
Oatly Group
OTLY
$533M
$36.7M 0.74% +1,500,000 New +$36.7M
FOLD icon
25
Amicus Therapeutics
FOLD
$2.34B
$36.2M 0.73% 3,750,000 – –
1
2 3 4 5